Renal Biomarker Market WITH Top 10 Players as BECKMAN COULTER, THERMO FISHER SCIENTIFIC, ABBOTT MOLECULAR, BIOPORTO A/S, ASTUTE MEDICAL, RANDOX LABORATORIES, SIEMENS HEALTHCARE DIAGNOSTICS

Renal Biomarker Market Highlights
The global renal biomarker market is expected to register a good CAGR during 2018-2023 (the forecast period). Kidney disease is a major cause of deaths worldwide. With the increasing incidences of chronic kidney diseases, especially, among the geriatric population, the need for novel biomarkers for early detection of the disease is increasing. Biomarkers are the signs or indicators of a medical state that is observed from outside the patient’s body, measured accurately and reproducibly. At present, serum creatinine, which is used to measure the glomerular filtration rate (GFR), is the most common marker for renal function.

Get your sample report now @ https://marketprognosis.com/sample-request/16813
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Rising Prevalence of Various Kidney-related Diseases
Currently, kidney-related issues are increasing across the world. According to the global report on care delivery for kidney diseases, it has been estimated that, globally, one in every 10 people suffer from some kind of kidney disease. For example, according to the information provided by the National Institute of Diabetes and Digestive and Kidney Diseases, the prevalence of CKD (chronic kidney disease) in the general population is at about 14% and over 661,000 Americans are suffering from kidney failure. Of these, 468,000 people are on dialysis, and roughly 193,000 are living with a functioning kidney transplant. In 2013, more than 47,000 US citizens died of kidney diseases. The global prevalence rate is increasing every year. Therefore, the market for renal biomarkers is expected to grow, as they are helpful for the detection of kidney diseases.
Additionally, other factors, such as high prevalence of diabetes and high blood pressure, which lead to renal diseases, along with rapid technological advances in the field of genetics, are driving the market growth.

Key Developments in the Market:
December 2017 u2013 Thermo Fisher Scientific acquired Phenom-World.

Major Players:
BECKMAN COULTER INC., THERMO FISHER SCIENTIFIC INC., ABBOTT MOLECULAR INC., BIOPORTO A/S, ASTUTE MEDICAL INC., RANDOX LABORATORIES LTD, SIEMENS HEALTHCARE DIAGNOSTICS INC., ALERE INC., and F. HOFFMANN-LA ROCHE AG, amongst others.

Get Discount on this report @ https://marketprognosis.com/discount-request/16813
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Issues related to Regulatory and Reimbursement Systems
The lack of proper reimbursement systems around the world is a major restraining factor for the global renal biomarker market. The process of securing reimbursement and funding for a diagnostic test for renal diseases is extremely challenging anywhere in the world. Stakeholders need to recognize what knowledge the payers/purchasers are looking for. This asks for an extensive research and interpretation of a very large amount of data. Moreover, international reimbursement structures vary from country to country, hence, interested parties have to come up now and then with new and effective strategies. Therefore, the strategies need to be altered as per the target market, making it a cumbersome and tedious task. Moreover, the developers and marketers of biomarkers have to go through a time-consuming and resource-intensive regulatory procedure, in order to bring their biomarkers to the market. They not only have to clear the US FDA hurdles, but also have to gain the confidence of the payers to obtain insurance coverage and payment for their devices. As a result, several companies tend to avoid this and altogether drop the idea of entering the market studied. These lengthy reimbursement procedures are expected to hinder the growth of the renal biomarker market over the forecast period.

The US to Lead the Market in North America
In 2017, the US renal biomarker market held the largest market share in North America, due to the presence of high-quality healthcare system, along with the prevalence rate of kidney diseases being high in this region.

For More Information, Please Visit @ https://marketprognosis.com/enquiry/16813
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.